vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and CPI AEROSTRUCTURES INC (CVU). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $19.4M, roughly 1.0× CPI AEROSTRUCTURES INC). CPI AEROSTRUCTURES INC runs the higher net margin — 3.6% vs -541.1%, a 544.7% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -10.8%). CPI AEROSTRUCTURES INC produced more free cash flow last quarter ($-2.1M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 0.9%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
AGIO vs CVU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $19.4M |
| Net Profit | $-108.0M | $691.8K |
| Gross Margin | 90.6% | 20.3% |
| Operating Margin | -608.9% | 6.4% |
| Net Margin | -541.1% | 3.6% |
| Revenue YoY | 86.1% | -10.8% |
| Net Profit YoY | -11.9% | -28.8% |
| EPS (diluted) | $-1.86 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $19.4M | ||
| Q3 25 | $12.9M | $19.3M | ||
| Q2 25 | $12.5M | $15.2M | ||
| Q1 25 | $8.7M | $15.4M | ||
| Q4 24 | $10.7M | $21.8M | ||
| Q3 24 | $9.0M | $19.4M | ||
| Q2 24 | $8.6M | $20.8M | ||
| Q1 24 | $8.2M | $19.1M |
| Q4 25 | $-108.0M | $691.8K | ||
| Q3 25 | $-103.4M | $1.1M | ||
| Q2 25 | $-112.0M | $-1.3M | ||
| Q1 25 | $-89.3M | $-1.3M | ||
| Q4 24 | $-96.5M | $971.5K | ||
| Q3 24 | $947.9M | $749.7K | ||
| Q2 24 | $-96.1M | $1.4M | ||
| Q1 24 | $-81.5M | $168.2K |
| Q4 25 | 90.6% | 20.3% | ||
| Q3 25 | 87.0% | 22.3% | ||
| Q2 25 | 86.3% | 4.4% | ||
| Q1 25 | 87.6% | 10.7% | ||
| Q4 24 | 88.3% | 20.0% | ||
| Q3 24 | 91.3% | 21.7% | ||
| Q2 24 | 82.6% | 24.6% | ||
| Q1 24 | 92.3% | 18.6% |
| Q4 25 | -608.9% | 6.4% | ||
| Q3 25 | -907.4% | 9.1% | ||
| Q2 25 | -1020.1% | -13.1% | ||
| Q1 25 | -1222.0% | -7.7% | ||
| Q4 24 | -1165.3% | 9.5% | ||
| Q3 24 | -1146.9% | 7.6% | ||
| Q2 24 | -1228.3% | 11.2% | ||
| Q1 24 | -1124.3% | 4.4% |
| Q4 25 | -541.1% | 3.6% | ||
| Q3 25 | -803.1% | 5.8% | ||
| Q2 25 | -899.4% | -8.7% | ||
| Q1 25 | -1023.3% | -8.6% | ||
| Q4 24 | -899.6% | 4.5% | ||
| Q3 24 | 10574.7% | 3.9% | ||
| Q2 24 | -1115.7% | 6.8% | ||
| Q1 24 | -995.8% | 0.9% |
| Q4 25 | $-1.86 | $0.04 | ||
| Q3 25 | $-1.78 | $0.09 | ||
| Q2 25 | $-1.93 | $-0.10 | ||
| Q1 25 | $-1.55 | $-0.10 | ||
| Q4 24 | $-1.44 | $0.08 | ||
| Q3 24 | $16.22 | $0.06 | ||
| Q2 24 | $-1.69 | $0.11 | ||
| Q1 24 | $-1.45 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $1.2B | $25.8M |
| Total Assets | $1.3B | $75.2M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | — | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — | ||
| Q1 24 | $118.8M | — |
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $26.5K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $25.8M | ||
| Q3 25 | $1.3B | $25.0M | ||
| Q2 25 | $1.4B | $23.8M | ||
| Q1 25 | $1.5B | $24.9M | ||
| Q4 24 | $1.5B | $25.9M | ||
| Q3 24 | $1.6B | $24.9M | ||
| Q2 24 | $660.5M | $24.1M | ||
| Q1 24 | $743.9M | $22.5M |
| Q4 25 | $1.3B | $75.2M | ||
| Q3 25 | $1.4B | $74.1M | ||
| Q2 25 | $1.5B | $72.3M | ||
| Q1 25 | $1.6B | $65.4M | ||
| Q4 24 | $1.7B | $68.0M | ||
| Q3 24 | $1.8B | $68.9M | ||
| Q2 24 | $773.1M | $70.2M | ||
| Q1 24 | $849.7M | $70.8M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-2.1M |
| Free Cash FlowOCF − Capex | $-97.3M | $-2.1M |
| FCF MarginFCF / Revenue | -487.5% | -10.8% |
| Capex IntensityCapex / Revenue | 5.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | -3.03× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-5.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-2.1M | ||
| Q3 25 | $-88.2M | $212.1K | ||
| Q2 25 | $-77.1M | $-596.3K | ||
| Q1 25 | $-111.5M | $-2.7M | ||
| Q4 24 | $-133.2M | $4.4M | ||
| Q3 24 | $-84.2M | $715.1K | ||
| Q2 24 | $-72.6M | $-591.7K | ||
| Q1 24 | $-99.9M | $-960.5K |
| Q4 25 | $-97.3M | $-2.1M | ||
| Q3 25 | $-89.7M | $211.1K | ||
| Q2 25 | $-78.0M | $-599.8K | ||
| Q1 25 | $-112.3M | $-2.8M | ||
| Q4 24 | $-134.1M | $4.3M | ||
| Q3 24 | $-84.6M | $586.9K | ||
| Q2 24 | $-72.7M | $-746.9K | ||
| Q1 24 | $-100.0M | $-1.0M |
| Q4 25 | -487.5% | -10.8% | ||
| Q3 25 | -696.5% | 1.1% | ||
| Q2 25 | -626.2% | -4.0% | ||
| Q1 25 | -1286.4% | -18.1% | ||
| Q4 24 | -1250.1% | 19.9% | ||
| Q3 24 | -944.2% | 3.0% | ||
| Q2 24 | -844.4% | -3.6% | ||
| Q1 24 | -1221.2% | -5.3% |
| Q4 25 | 5.6% | 0.0% | ||
| Q3 25 | 12.1% | 0.0% | ||
| Q2 25 | 7.0% | 0.0% | ||
| Q1 25 | 8.8% | 0.4% | ||
| Q4 24 | 9.0% | 0.3% | ||
| Q3 24 | 4.7% | 0.7% | ||
| Q2 24 | 1.8% | 0.7% | ||
| Q1 24 | 1.7% | 0.2% |
| Q4 25 | — | -3.03× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | -0.09× | 0.95× | ||
| Q2 24 | — | -0.42× | ||
| Q1 24 | — | -5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
